palmitoylcarnitine has been researched along with sphingosine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bergstrand, H; Karabelas, K; Lundquist, B; Michelsen, P | 1 |
| Buzilã, L; Laky, M; Moraru, II; Popescu, LM; Stãnescu, T | 1 |
| Arese, P; Bussolino, F; Fischer, E; Kazatchkine, MD; Turrini, F | 1 |
| McIntyre, TM; Prescott, SM; Reinhold, SL; Zimmerman, GA | 1 |
| Grove, DS; Mastro, AM | 1 |
| Epand, RM; McCallum, CD | 1 |
| Muraki, K | 1 |
| Imaizumi, Y; Muraki, K | 1 |
| Fonfria, E; Michel, AD | 1 |
| Burrows, LL; Chong, MA; Koteva, K; Nguyen, UT; Wenderska, IB; Wright, GD | 1 |
| Chen, H; Chen, K; Chen, L; Hu, Y; Huang, D; Jin, S; Ju, M; Li, R; Liu, L; Luan, C; Wang, Z; Zhang, J; Zhou, X | 1 |
1 review(s) available for palmitoylcarnitine and sphingosine
| Article | Year |
|---|---|
[Analyses of Ca-related ion channel currents and their involvement in Ca mobilization in smooth muscle and endothelial cells].
Topics: Animals; Calcium; Calcium Channels; Chloride Channels; Cromakalim; Endothelium; Humans; Lysophospholipids; Membrane Potentials; Muscle, Smooth; Nifedipine; Palmitoylcarnitine; Potassium Channels; Sphingosine | 2003 |
10 other study(ies) available for palmitoylcarnitine and sphingosine
| Article | Year |
|---|---|
Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Basophils; Calcimycin; Glyceryl Ethers; Histamine Release; Humans; Indoles; Isoquinolines; Maleimides; Mannitol; Palmitoylcarnitine; Piperazines; Polymyxin B; Protein Kinase C; Sphingosine; Staurosporine; Sulfonamides; Tetradecanoylphorbol Acetate | 1992 |
Protein kinase C controls Fc gamma receptor-mediated endocytosis in human neutrophils.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Antigens, Differentiation; Cells, Cultured; Endocytosis; Humans; Immunoglobulin G; Isoquinolines; Kinetics; Neutrophils; Palmitoylcarnitine; Piperazines; Protein Kinase C; Receptors, Fc; Receptors, IgG; Signal Transduction; Sphingosine; Tamoxifen | 1990 |
Platelet-activating factor enhances complement-dependent phagocytosis of diamide-treated erythrocytes by human monocytes through activation of protein kinase C and phosphorylation of complement receptor type one (CR1).
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Azo Compounds; Cell Adhesion; Complement System Proteins; Diamide; Enzyme Activation; Erythrocytes; Humans; In Vitro Techniques; Isoquinolines; Kinetics; Monocytes; Palmitoylcarnitine; Phagocytosis; Phosphorylation; Piperazines; Platelet Activating Factor; Protein Kinase C; Receptors, Complement; Sphingosine; Staurosporine; Structure-Activity Relationship | 1989 |
Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils.
Topics: Amines; Enzyme Activation; Humans; Leukotriene B4; Neutrophils; Palmitoylcarnitine; Platelet Activating Factor; Protein Kinase C; Sphingosine; Tetradecanoylphorbol Acetate | 1987 |
Prevention of the TPA-mediated down-regulation of protein kinase C.
Topics: Animals; Cattle; Lymphocytes; Palmitoylcarnitine; Phloretin; Protein Kinase C; Sphingosine; Tetradecanoylphorbol Acetate | 1988 |
Insulin receptor autophosphorylation and signaling is altered by modulation of membrane physical properties.
Topics: 3T3 Cells; Animals; Apolipoprotein A-I; Biophysical Phenomena; Biophysics; Carnitine; Cell Membrane; Dipeptides; Glucose; Insulin; Laurates; Lipid Bilayers; Lysophosphatidylcholines; Mice; Palmitoylcarnitine; Phosphorylation; Receptor, Insulin; Signal Transduction; Sphingosine; Temperature | 1995 |
A novel action of palmitoyl-L-carnitine in human vascular endothelial cells.
Topics: Calcium; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Lysophospholipids; Palmitoylcarnitine; Sphingosine; Umbilical Veins | 2003 |
Agonist potency at P2X7 receptors is modulated by structurally diverse lipids.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dose-Response Relationship, Drug; Ethidium; Fluorometry; Humans; Interleukin-1beta; Lipids; Lysophosphatidylcholines; Mice; Octoxynol; Palmitoylcarnitine; Phosphorylcholine; Purinergic P2 Receptor Agonists; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X7; Sphingosine; Surface-Active Agents | 2007 |
Small-molecule modulators of Listeria monocytogenes biofilm development.
Topics: Anti-Bacterial Agents; Biofilms; Enzyme Inhibitors; Fatty Acids; Listeria monocytogenes; Microbial Sensitivity Tests; Palmitoylcarnitine; Protein Kinases; Sphingosine; Structure-Activity Relationship | 2012 |
Landscape of circulating metabolic fingerprinting for keloid.
Topics: Humans; Keloid; Logistic Models; Palmitoylcarnitine; Phosphorylcholine; Sphingosine | 2022 |